Deviated Septum Treatment — Cost, Top Hospitals & Success Rates | MyMedicPlus

Deviated septum treatment addresses a displacement of the nasal septum — the thin wall of cartilage and bone that divides the nasal cavity into left and right airways — from the midline. While some degree of septal asymmetry is nearly universal (estimated in 80% of the population), clinically significant deviation causing symptomatic nasal obstruction is present in approximately 20–30% of adults. The septum may be displaced due to developmental asymmetry, nasal trauma (contact sports, accidents, boxing), or congenital factors.

Non-surgical management is the first approach for mild to moderate symptoms. Intranasal corticosteroid sprays (fluticasone, mometasone) reduce mucosal swelling overlying the deviation, improving airflow without addressing the underlying structural problem. Saline nasal irrigation (neti pot or nasal spray) reduces crusting and promotes healthy mucosal function. Decongestants provide short-term symptom relief but should not be used for more than 3–5 days due to rebound congestion (rhinitis medicamentosa). Antihistamines are useful when concurrent allergic rhinitis contributes to symptoms.

When conservative measures fail to provide adequate relief, surgical correction via septoplasty is the definitive treatment. Septoplasty is performed under general anaesthesia through an endonasal approach (incisions inside the nose, leaving no external scars). The surgeon elevates the mucoperichandrium (lining of the septum) off the cartilage and bone, removes, reshapes, and replaces the deviated components, then repositions the mucosal lining. The procedure takes 60–90 minutes and is typically performed as day surgery. Combined septorhinoplasty addresses both functional septal correction and external nasal shape modification in patients who desire both functional and cosmetic nasal improvement.

Septoplasty is among the most commonly performed ENT procedures globally, with consistently high patient satisfaction rates for symptom resolution. It is a technically demanding procedure requiring meticulous submucosal dissection to avoid complications such as septal perforation.

Deviated septum treatment addresses nasal obstruction — the primary symptom — where the deviated septum narrows one or both nasal airways, causing difficulty breathing through the nose. This manifests as unilateral or bilateral nasal blockage, preference for mouth breathing, reduced exercise tolerance, and disrupted sleep. Nasal obstruction from septal deviation is a significant contributor to snoring and obstructive sleep apnoea (OSA) — septoplasty may be recommended as part of a comprehensive OSA treatment plan, though it rarely cures OSA in isolation without concurrent turbinate reduction or CPAP.

Recurrent sinusitis is another major indication, where structural deviation blocks sinus drainage pathways (particularly the osteomeatal complex in the middle meatus), creating a predisposition to acute and chronic sinusitis. Epistaxis (nosebleeds) can occur when the deviated portion of the septum creates turbulent airflow that desiccates and cracks the mucosa, and when prominent nasal spurs disrupt the mucosal blood supply. Anosmia or hyposmia (reduced sense of smell) related to obstructed olfactory airflow can improve after septal correction. External nasal deformity from severe C-shaped or S-shaped septal deviations that cause visible asymmetry of the external nose requires combined septorhinoplasty for complete correction.

Ideal candidates for septoplasty are adults (over 18 years, when nasal growth is complete) with nasal obstruction that has failed adequate non-surgical management, with clinical nasal examination and anterior rhinoscopy or nasal endoscopy confirming that the septum is the primary obstructing structure. CT imaging of the paranasal sinuses provides additional structural detail for complex or revision cases. Patients with documented obstructive sleep apnoea where nasal obstruction is a contributing factor are particularly good candidates. Patients seeking combined functional and cosmetic correction (septorhinoplasty) are appropriate candidates when both indications are present.

Contraindications include active nasal infection (rhinitis, sinusitis — surgery should be deferred until infection is controlled); uncontrolled bleeding disorders; poorly controlled hypertension; patients under 16–18 years where nasal cartilage growth is ongoing (septoplasty can be performed earlier for severely obstructive deviations when growth is monitored); and patients with unrealistic expectations about the outcome of functional septoplasty. Patients using aspirin, anticoagulants, or anti-platelet agents need to discontinue these before surgery as guided by the prescribing physician and anaesthetist.

Standard endonasal septoplasty involves a hemitransfixion or Killian incision inside the nasal vestibule, submucoperiosteal and submucopericondrial dissection to expose the deviated cartilage and bone, excision or reshaping of the deviated portions while preserving structural support to the nasal tip and dorsum, and mucosal repositioning. Internal splints (silastic sheets or thermoplastic splints) placed inside the nose for 1–2 weeks post-operatively support the repositioned septum and prevent haematoma. Packing (gel foam or biodegradable haemostat) may be used temporarily to control oozing.

Endoscopic-guided septoplasty uses a 0-degree or 30-degree endoscope providing illuminated magnified visualisation, allowing more precise and complete correction of posterior deviations (septal spurs, posterior deviations at the vomer-septal junction) compared to headlight-only surgery. Extracorporeal septoplasty — removal, reshaping, and reimplantation of the entire quadrangular cartilage — is reserved for severe cartilaginous deviations where in situ correction is insufficient. Submucosal resection (SMR) — the older procedure removing a larger portion of the septal skeleton — has largely been replaced by more conservative techniques that preserve septal support. Turbinate reduction (inferior turbinoplasty, turbinate out-fracture, or submucosal diathermy) is frequently performed concurrently with septoplasty when hypertrophied turbinates are contributing to obstruction. Shared decision-making between patient and specialist, guided by current evidence-based clinical guidelines and the patient's individual anatomy, comorbidities, and treatment goals, is essential for selecting the most appropriate treatment modality. Pre-treatment specialist consultation, review of relevant investigations, and multidisciplinary input for complex presentations ensure the best possible outcomes.

Septoplasty produces significant, long-lasting improvement in nasal airflow in appropriately selected patients. Patient-reported outcome measures (PROM) using validated nasal obstruction symptom evaluation (NOSE) scores show clinically meaningful improvement in 75–85% of patients at 12 months. Rhinomanometry (objective airflow measurement) confirms improved nasal flow in the majority of successfully operated patients. Snoring and sleep quality improvements are reported by patients and bed partners following septoplasty, particularly when combined with concurrent turbinate reduction.

Related symptoms including recurrent sinusitis (reduced sinus drainage obstruction), epistaxis (normalised airflow prevents desiccation-related bleeding), and exercise intolerance often improve following septal correction. The cosmetic improvement from combined septorhinoplasty addressing both the septum and external nasal shape produces high patient satisfaction — studies consistently report 80–90% satisfaction rates when the procedure is performed by an experienced rhinoplasty surgeon. Septoplasty in patients with OSA reduces CPAP pressure requirements and improves CPAP compliance, making it a valuable component of a comprehensive sleep apnoea treatment pathway.

Septal haematoma — collection of blood between the septal mucosal flaps — is the most urgent post-operative complication, presenting as bilateral nasal obstruction and swelling within 24 hours of surgery. It requires urgent drainage to prevent cartilage necrosis and secondary infection. Its incidence is reduced by careful intraoperative haemostasis and use of internal splints. Post-operative nasal bleeding occurs in 1–2% of cases and may require repacking or cauterisation.

Septal perforation — a hole through the nasal septum — is a serious long-term complication (occurring in less than 1% of cases with modern technique) causing a persistent whistling sound, epistaxis, crusting, and discomfort. Large perforations may require surgical repair with mucosal flaps or silastic obturators. Temporary reduction in sense of smell (hyposmia) is common post-operatively due to mucosal oedema and resolves within weeks. Persistent changes in olfaction are rare. Failure to adequately improve nasal obstruction occurs in 15–25% of cases — reasons include incomplete correction of the deviation, concurrent turbinate hypertrophy not addressed, nasal valve collapse, or adhesion formation. Revision septoplasty may be required. Rare risks include intracranial complications from penetration of the cribriform plate, though this is exceedingly rare with standard endonasal technique.

Immediately post-operatively, patients experience significant nasal congestion, mild pain, and occasional oozing. Internal splints (if used) are removed at 5–7 days. Saline nasal irrigation starting from day 2 post-operatively flushes out blood clots and crusts, promoting mucosal healing and reducing the risk of adhesion formation. Patients should avoid blowing the nose forcefully for 2 weeks. Strenuous exercise, contact sports, and activities risking nasal trauma should be avoided for 3–4 weeks. Most patients return to sedentary work within 7–10 days.

Follow-up appointments at 1 week (splint removal), 4 weeks (assessment of mucosal healing), and 3 months (evaluation of functional result) are standard. Final assessment of the functional result should be deferred to 6 months as the mucosal oedema completely resolves over this period. Patients undergoing combined septorhinoplasty require 12 months for full external shape assessment as skin thickness adaptation to the reshaped framework continues. Saline sprays can be continued long-term to maintain mucosal health. Patients should protect the nose from trauma during sport with appropriate face guards for at least 3 months post-operatively.

Septoplasty costs vary by country and healthcare system. In the United States, septoplasty (functional) costs USD 6,000–15,000 at a private surgical facility, though it is typically covered by health insurance when medically indicated nasal obstruction is documented with objective testing. Combined septorhinoplasty (functional + cosmetic) costs USD 8,000–20,000, with the cosmetic component typically excluded from insurance coverage. In the United Kingdom, NHS covers septoplasty for functional nasal obstruction meeting clinical criteria; private septoplasty costs GBP 4,000–10,000.

Medical tourism for septoplasty offers significant savings. In India, septoplasty costs USD 800–2,500 performed by an ENT specialist at an accredited hospital; combined septorhinoplasty costs USD 1,500–4,000. Thailand and Turkey offer septoplasty at USD 1,200–3,500. For patients combining functional correction with rhinoplasty, Turkey has become particularly well-regarded for nose surgery at 70–80% savings vs US prices. JCI-accredited ENT centres in these countries use the same surgical techniques and endoscopic equipment as Western practice. Pre-operative nasal CT and post-operative nasal endoscopy should be arranged through the visiting centre or facilitated locally after returning home.

Non-surgical alternatives for symptomatic management of mild-to-moderate septal deviation include intranasal corticosteroid sprays as the mainstay of medical management, nasal dilator strips (Breathe Right) worn during sleep to reduce nasal resistance at the nasal valve level, and nasal stents or dilators for athletes. These measures improve nasal airflow without addressing the underlying deviation and require ongoing use.

For patients with obstructive sleep apnoea, CPAP therapy is the gold-standard treatment for moderate-to-severe OSA regardless of septal anatomy — septoplasty alone rarely cures OSA but improves CPAP tolerance. Radiofrequency coblation turbinoplasty as an isolated procedure is appropriate when inferior turbinate hypertrophy is the primary obstructing factor with only minimal septal contribution. Nasal valve surgery (spreader grafts, alar batten grafts) specifically addresses nasal valve collapse — a cause of nasal obstruction distinct from septal deviation that may coexist and requires concurrent treatment.